1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Spinal Muscular Atrophy (SMA) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Oral Medicine 1.2.3 Injection Medicine 1.3 Market by Application 1.3.1 Global Spinal Muscular Atrophy (SMA) Drugs Market Share by End User: 2016 VS 2021 VS 2027 1.3.2 Baby 1.3.3 Child 1.3.4 Adult 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Spinal Muscular Atrophy (SMA) Drugs Market Perspective (2016-2027) 2.2 Spinal Muscular Atrophy (SMA) Drugs Growth Trends by Regions 2.2.1 Spinal Muscular Atrophy (SMA) Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Spinal Muscular Atrophy (SMA) Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Spinal Muscular Atrophy (SMA) Drugs Industry Dynamic 2.3.1 Spinal Muscular Atrophy (SMA) Drugs Market Trends 2.3.2 Spinal Muscular Atrophy (SMA) Drugs Market Drivers 2.3.3 Spinal Muscular Atrophy (SMA) Drugs Market Challenges 2.3.4 Spinal Muscular Atrophy (SMA) Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Spinal Muscular Atrophy (SMA) Drugs Players by Revenue 3.1.1 Global Top Spinal Muscular Atrophy (SMA) Drugs Players by Revenue (2016-2021) 3.1.2 Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Spinal Muscular Atrophy (SMA) Drugs Revenue 3.4 Global Spinal Muscular Atrophy (SMA) Drugs Market Concentration Ratio 3.4.1 Global Spinal Muscular Atrophy (SMA) Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Drugs Revenue in 2020 3.5 Spinal Muscular Atrophy (SMA) Drugs Key Players Head office and Area Served 3.6 Key Players Spinal Muscular Atrophy (SMA) Drugs Product Solution and Service 3.7 Date of Enter into Spinal Muscular Atrophy (SMA) Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Spinal Muscular Atrophy (SMA) Drugs Breakdown Data by Type 4.1 Global Spinal Muscular Atrophy (SMA) Drugs Historic Market Size by Type (2016-2021) 4.2 Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Type (2022-2027) 5 Spinal Muscular Atrophy (SMA) Drugs Breakdown Data by End User 5.1 Global Spinal Muscular Atrophy (SMA) Drugs Historic Market Size by End User (2016-2021) 5.2 Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by End User (2022-2027) 6 North America 6.1 North America Spinal Muscular Atrophy (SMA) Drugs Market Size (2016-2027) 6.2 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type 6.2.1 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) 6.2.2 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) 6.2.3 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2027) 6.3 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User 6.3.1 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) 6.3.2 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) 6.3.3 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2027) 6.4 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country 6.4.1 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2016-2021) 6.4.2 North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size (2016-2027) 7.2 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type 7.2.1 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) 7.2.2 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) 7.2.3 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2027) 7.3 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by End User 7.3.1 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) 7.3.2 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) 7.3.3 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2027) 7.4 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country 7.4.1 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2016-2021) 7.4.2 Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size (2016-2027) 8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type 8.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by End User 8.3.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) 8.3.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) 8.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2027) 8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region 8.4.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size (2016-2027) 9.2 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type 9.2.1 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2027) 9.3 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User 9.3.1 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) 9.3.2 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) 9.3.3 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2027) 9.4 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country 9.4.1 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size (2016-2027) 10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type 10.2.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by End User 10.3.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) 10.3.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) 10.3.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2027) 10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country 10.4.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Biogen 11.1.1 Biogen Company Details 11.1.2 Biogen Business Overview 11.1.3 Biogen Spinal Muscular Atrophy (SMA) Drugs Introduction 11.1.4 Biogen Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) 11.1.5 Biogen Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Spinal Muscular Atrophy (SMA) Drugs Introduction 11.2.4 Novartis Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Genentech 11.3.1 Genentech Company Details 11.3.2 Genentech Business Overview 11.3.3 Genentech Spinal Muscular Atrophy (SMA) Drugs Introduction 11.3.4 Genentech Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) 11.3.5 Genentech Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Spinal Muscular Atrophy (SMA) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Oral Medicine Table 3. Key Players of Injection Medicine Table 4. Global Spinal Muscular Atrophy (SMA) Drugs Market Size Growth by End User (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Spinal Muscular Atrophy (SMA) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Spinal Muscular Atrophy (SMA) Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Regions (2016-2021) Table 8. Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Regions (2022-2027) Table 10. Spinal Muscular Atrophy (SMA) Drugs Market Trends Table 11. Spinal Muscular Atrophy (SMA) Drugs Market Drivers Table 12. Spinal Muscular Atrophy (SMA) Drugs Market Challenges Table 13. Spinal Muscular Atrophy (SMA) Drugs Market Restraints Table 14. Global Spinal Muscular Atrophy (SMA) Drugs Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Players (2016-2021) Table 16. Global Top Spinal Muscular Atrophy (SMA) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Drugs as of 2020) Table 17. Ranking of Global Top Spinal Muscular Atrophy (SMA) Drugs Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Drugs Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Spinal Muscular Atrophy (SMA) Drugs Product Solution and Service Table 21. Date of Enter into Spinal Muscular Atrophy (SMA) Drugs Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) (US$ Million) Table 24. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by Type (2016-2021) Table 25. Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Spinal Muscular Atrophy (SMA) Drugs Market Size Share by End User (2016-2021) & (US$ Million) Table 28. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by End User (2016-2021) Table 29. Global Spinal Muscular Atrophy (SMA) Drugs Forecasted Market Size by End User (2022-2027) (US$ Million) Table 30. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by End User (2022-2027) & (US$ Million) Table 31. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) (US$ Million) Table 32. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) (US$ Million) Table 34. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) & (US$ Million) Table 35. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) (US$ Million) Table 40. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) & (US$ Million) Table 41. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) (US$ Million) Table 46. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) & (US$ Million) Table 47. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) (US$ Million) Table 52. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) & (US$ Million) Table 53. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2016-2021) (US$ Million) Table 58. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by End User (2022-2027) & (US$ Million) Table 59. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size by Country (2022-2027) & (US$ Million) Table 61. Biogen Company Details Table 62. Biogen Business Overview Table 63. Biogen Spinal Muscular Atrophy (SMA) Drugs Product Table 64. Biogen Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) & (US$ Million) Table 65. Biogen Recent Development Table 66. Novartis Company Details Table 67. Novartis Business Overview Table 68. Novartis Spinal Muscular Atrophy (SMA) Drugs Product Table 69. Novartis Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) & (US$ Million) Table 70. Novartis Recent Development Table 71. Genentech Company Details Table 72. Genentech Business Overview Table 73. Genentech Spinal Muscular Atrophy (SMA) Drugs Product Table 74. Genentech Revenue in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) & (US$ Million) Table 75. Genentech Recent Development Table 76. Research Programs/Design for This Report Table 77. Key Data Information from Secondary Sources Table 78. Key Data Information from Primary Sources List of Figures Figure 1. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Type: 2020 VS 2027 Figure 2. Oral Medicine Features Figure 3. Injection Medicine Features Figure 4. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by End User: 2020 VS 2027 Figure 5. Baby Case Studies Figure 6. Child Case Studies Figure 7. Adult Case Studies Figure 8. Spinal Muscular Atrophy (SMA) Drugs Report Years Considered Figure 9. Global Spinal Muscular Atrophy (SMA) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Spinal Muscular Atrophy (SMA) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Regions: 2020 VS 2027 Figure 12. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Regions (2022-2027) Figure 13. Global Spinal Muscular Atrophy (SMA) Drugs Market Share by Players in 2020 Figure 14. Global Top Spinal Muscular Atrophy (SMA) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Drugs as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Drugs Revenue in 2020 Figure 16. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by Type (2016-2021) Figure 17. Global Spinal Muscular Atrophy (SMA) Drugs Revenue Market Share by Type (2022-2027) Figure 18. North America Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2016-2027) Figure 20. North America Spinal Muscular Atrophy (SMA) Drugs Market Share by End User (2016-2027) Figure 21. North America Spinal Muscular Atrophy (SMA) Drugs Market Share by Country (2016-2027) Figure 22. United States Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2016-2027) Figure 26. Europe Spinal Muscular Atrophy (SMA) Drugs Market Share by End User (2016-2027) Figure 27. Europe Spinal Muscular Atrophy (SMA) Drugs Market Share by Country (2016-2027) Figure 28. Germany Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2016-2027) Figure 36. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Share by End User (2016-2027) Figure 37. Asia-Pacific Spinal Muscular Atrophy (SMA) Drugs Market Share by Region (2016-2027) Figure 38. China Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2016-2027) Figure 46. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Share by End User (2016-2027) Figure 47. Latin America Spinal Muscular Atrophy (SMA) Drugs Market Share by Country (2016-2027) Figure 48. Mexico Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Share by Type (2016-2027) Figure 52. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Share by End User (2016-2027) Figure 53. Middle East & Africa Spinal Muscular Atrophy (SMA) Drugs Market Share by Country (2016-2027) Figure 54. Turkey Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Spinal Muscular Atrophy (SMA) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Biogen Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) Figure 58. Novartis Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) Figure 59. Genentech Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Drugs Business (2016-2021) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Biogen Novartis Genentech